IVVD stock news · Invivyd Inc.

Stories about Invivyd Inc. (IVVD) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IVVD

Follow Invivyd Inc. (IVVD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Sep 29, 2026, 2:48 PM ET · Trial
Invivyd is moving quickly to ask the FDA to approve its COVID-19 antibody.
Good for IVVD
Invivyd reported encouraging safety and antibody results for its COVID-19 treatment and plans to seek FDA approval. The treatment is not approved yet, but the study results support the company’s case.
Sep 29, 2026, 2:48 PM ET · Trial
Invivyd is getting ready to ask the FDA to quickly approve its COVID-19 antibody treatment.
Good for IVVD
Invivyd reported encouraging safety and antibody results and plans an FDA application. This is a positive step, but the study did not prove the drug prevents illness.
Sep 21, 2026, 1:30 PM ET · Market
On Monday, 12 health care stocks changed a lot in price during trading.
Neutral
Invivyd moved up 30.45% to $0.99, but only a price move and market cap are reported, leaving the company's outlook unchanged.